These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21751947)

  • 1. Antileukemic T-cell-mediated immune reactions: limitations and perspectives for future therapies.
    Schmetzer HM
    Immunotherapy; 2011 Jul; 3(7):809-11. PubMed ID: 21751947
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumors suppress in situ proliferation of cytotoxic T cells by promoting differentiation of Gr-1(+) conventional dendritic cells through IL-6.
    Diao J; Zhao J; Winter E; Cattral MS
    J Immunol; 2011 May; 186(9):5058-67. PubMed ID: 21430223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL21 Programs Immune Activity in Tumor Microenvironment.
    Sharma S; Kadam P; Dubinett S
    Adv Exp Med Biol; 2020; 1231():67-78. PubMed ID: 32060847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia.
    Klammer M; Roddie PH
    Expert Rev Vaccines; 2006 Apr; 5(2):211-22. PubMed ID: 16608421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: example of chronic myelogenous leukemia.
    Dietz AB; Litzow MR; Gastineau DA; Vuk-Pavlović S
    Croat Med J; 2001 Aug; 42(4):428-35. PubMed ID: 11471194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.
    Poggi A; Zocchi MR
    Arch Immunol Ther Exp (Warsz); 2006; 54(5):323-33. PubMed ID: 17031467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia cells fail to activate native human dendritic cells: a potential mechanism of immune evasion.
    Wehner R; Schumacher P; Bornhäuser M; Ehninger G; Schäkel K; Bachmann M; Schmitz M
    Leukemia; 2010 Nov; 24(11):1965-7. PubMed ID: 20811402
    [No Abstract]   [Full Text] [Related]  

  • 9. Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.
    Decker WK; Xing D; Li S; Robinson SN; Yang H; Yao X; Segall H; McMannis JD; Komanduri KV; Champlin RE; Shpall EJ
    Vaccine; 2006 Apr; 24(16):3203-16. PubMed ID: 16480795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulations.
    Schick J; Vogt V; Zerwes M; Kroell T; Kraemer D; Köhne CH; Hausmann A; Buhmann R; Tischer J; Schmetzer H
    J Immunother; 2013 May; 36(4):223-37. PubMed ID: 23603857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current strategies in immunotherapy for acute myeloid leukemia.
    Lichtenegger FS; Schnorfeil FM; Hiddemann W; Subklewe M
    Immunotherapy; 2013 Jan; 5(1):63-78. PubMed ID: 23256799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape from IFN-γ-dependent immunosurveillance in tumorigenesis.
    Lin CF; Lin CM; Lee KY; Wu SY; Feng PH; Chen KY; Chuang HC; Chen CL; Wang YC; Tseng PC; Tsai TT
    J Biomed Sci; 2017 Feb; 24(1):10. PubMed ID: 28143527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell vaccines in acute leukaemia.
    Duncan C; Roddie H
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escape from T-cell-targeting immunotherapies in acute myeloid leukemia.
    Vadakekolathu J; Rutella S
    Blood; 2024 Jun; 143(26):2689-2700. PubMed ID: 37467496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated dormancy: an equilibrium with cancer.
    Teng MW; Swann JB; Koebel CM; Schreiber RD; Smyth MJ
    J Leukoc Biol; 2008 Oct; 84(4):988-93. PubMed ID: 18515327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
    Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
    Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
    Zhong RK; Lane TA; Ball ED
    Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of radiation therapy on the antitumor immunity: local effects and systemic consequences.
    Lumniczky K; Sáfrány G
    Cancer Lett; 2015 Jan; 356(1):114-25. PubMed ID: 23994343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
    Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
    J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.